CapsoVision, Inc.'s IPO exhibits high risks with slowing revenue growth, rising losses, and excessive valuation. Learn why a ...

This important study advances our understanding of population-level immune responses to influenza in both children and adults. The strength of the evidence supporting the conclusions is compelling, ...